Screener
Zevra Therapeutics, Inc. ZVRA Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note M) | ||
| Stockholders’ equity: | ||
| Preferred stock: | ||
| Undesignated preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2026, or December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 250,000,000 shares authorized; 60,917,598 shares issued and 59,341,906 shares outstanding as of June 30, 2026; 58,338,319 shares issued and 56,854,781 shares outstanding as of December 31, 2025 | 6 | 6 |
| Additional paid-in capital | 606,264 | 588,458 |
| Treasury stock, at cost | (10,983) | (10,983) |
| Accumulated deficit | (375,418) | (422,060) |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s preferred stock, shares authorized?
- Zevra Therapeutics, Inc. (ZVRA) reported preferred stock, shares authorized of $10M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s preferred stock, shares authorized changed year-over-year?
- Zevra Therapeutics, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about Zevra Therapeutics, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude